Smart pen tested to help arthritis patients stick with treatment
NCT ID NCT05891600
Summary
This study looked at whether a smart electronic device for injecting the rheumatoid arthritis drug etanercept helps patients take their medication more consistently. Researchers reviewed the medical records of 60 patients in Colombia over 40 weeks to see if using the device improved their adherence and their arthritis symptoms. The study did not test a new cure, but rather a tool to help manage the chronic condition with existing medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biomab Ips S.A.S.
Bogotá, 110231, Colombia
Conditions
Explore the condition pages connected to this study.